JOINN(603127.SH)

Last Updated 00:00:00

JOINN Stock Performance Chart

longbridge loading
Company Encyclopedia
View More
name
JOINN
603127.SH
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies.
601.73 B
603127.SHMarket value -Rank by Market Cap -/-

Financial Score

20/04/2026 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking10/27
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.63%C
    • Profit Margin17.97%A
    • Gross Margin16.98%D
  • Growth ScoreD
    • Revenue YoY-17.87%E
    • Net Profit YoY302.08%A
    • Total Assets YoY3.04%C
    • Net Assets YoY3.05%C
  • Cash ScoreC
    • Cash Flow Margin149.26%B
    • OCF YoY-17.87%E
  • Operating ScoreD
    • Turnover0.17D
  • Debt ScoreA
    • Gearing Ratio14.01%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The Hang Seng Index opened up 0.27%, and the Hang Seng TECH Index rose 0.08%

    36Kr·
    SH
    601600
    -2.99%
    SH
    515030
    -0.40%
    SZ
    159306
    +0.51%
    36Kr·
    SH
    601600
    -2.99%
    SH
    515030
    -0.40%
    SZ
    159306
    +0.51%

    JOINN's annual net profit is 298 million RMB, a threefold increase, with a final dividend of 12 cents

    AASTOCKS·
    HK
    06127
    +3.55%
    SH
    516930
    -0.20%
    SH
    603127
    +1.98%
    AASTOCKS·
    HK
    06127
    +3.55%
    SH
    516930
    -0.20%
    SH
    603127
    +1.98%

    The Hong Kong innovative drug sector continued to rise in the afternoon, with JOINN and CSPC PHARMA up over 10%, INNOVENT BIO up over 7%, and JUNSHI BIO and INNOCARE following suit

    Wallstreetcn·
    SH
    513120
    -0.23%
    HK
    01801
    -0.44%
    SH
    603127
    +1.98%
    Wallstreetcn·
    SH
    513120
    -0.23%
    HK
    01801
    -0.44%
    SH
    603127
    +1.98%

    JOINN: Shareholders Gu Xiaolei and Gu Meifang plan to adjust the total reduction ratio from no more than 4.1026% of the company's total share capital to 3.00%, while changing the reduction method from centralized bidding to a combination of centralized bidding and block trading

    Wallstreetcn·
    SH
    603127
    +1.98%
    US
    FBT
    -0.33%
    HK
    06127
    +3.55%
    Wallstreetcn·
    SH
    603127
    +1.98%
    US
    FBT
    -0.33%
    HK
    06127
    +3.55%

    The Hang Seng Index closed down 2.14%, and the Hang Seng Technology Index fell 2.89%

    36Kr·
    HK
    00HSI
    +0.77%
    SH
    603127
    +1.98%
    HK
    06127
    +3.55%
    36Kr·
    HK
    00HSI
    +0.77%
    SH
    603127
    +1.98%
    HK
    06127
    +3.55%
    © 2026 Longbridge｜Disclaimer